Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: perspectives from Taiwan

7 月 31, 2020 轉譯文章

本文描述台灣細胞病理學實驗室的感染控制與預防。

(財團法人國家衛生研究院 莊淑鈞博士摘要整理)

Author：Chien-Chin Chen, Chia-Yu Chi

原文連結：https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncy.22280

Post Views: 400

Related Post

你是在什麼時候決定要打疫苗呢？或是你也正在擔心哪些親朋好友還沒有打疫苗？(Utilizing Internet Search Volume to Monitor Stages of Change in Vaccine Hesitancy During the COVID-19 Outbreaks)

7 月 5, 2022

SARS-CoV-2突破性感染後的長新冠 (Long COVID after breakthrough SARS-CoV-2 infection)

6 月 1, 2022

mRNA-1273 COVID-19疫苗於6至11歲兒童的使用評估 (Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age)

5 月 16, 2022